This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management of chronic hypertension in postnal period

Authoring team

Chronic hypertension - postnatal period

  • in women with chronic hypertension, blood pressure measurement after birth should be done
    • daily for the first 2 days after birth
    • at least once between day 3 and day 5 after birth
    • as clinically indicated if antihypertensive treatment is changed after birth
  • in women with chronic hypertension who have given birth, aim to keep blood pressure lower than 140/90 mmHg
  • in women with chronic hypertension who have given birth:
    • continue antenatal antihypertensive treatment
    • review long-term antihypertensive treatment 2 weeks after the birth
  • if a woman has taken methyldopa to treat chronic hypertension during pregnancy, stop within 2 days of birth and restart the antihypertensive treatment the woman was taking before she planned the pregnancy
  • offer women with chronic hypertension a medical review at the postnatal review (6-8 weeks after the birth) with the pre-pregnancy care team

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.